GENFIT TOWARDS BETTER MEDICINE Trademark

Trademark Overview

On Friday, August 29, 2025, a trademark application was filed for GENFIT TOWARDS BETTER MEDICINE with the United States Patent and Trademark Office. The USPTO has given the GENFIT TOWARDS BETTER MEDICINE trademark a serial number of 79434062. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, January 16, 2026. This trademark is owned by GENFIT. The GENFIT TOWARDS BETTER MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; chemical preparations for medical use, for pharmaceutical use, for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; biological preparations for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; cell preparations for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer, in particular for gene therapy...
genfit towards better medicine

General Information

Serial Number79434062
Word MarkGENFIT TOWARDS BETTER MEDICINE
Filing DateFriday, August 29, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateFriday, January 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; chemical preparations for medical use, for pharmaceutical use, for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; biological preparations for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer; cell preparations for medical use, for pharmaceutical use for the prevention and treatment of liver diseases, metabolic diseases, gastroenterological diseases, gastrointestinal diseases, inflammatory diseases, immune disorders and cancer, in particular for gene therapy and cell therapy; kits for preparing cells or for selecting biologically active compounds; diagnostic products for medical or veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology
Pseudo MarkGEN FIT TOWARDS BETTER MEDICINE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENFIT
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Thursday, October 2, 2025SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, October 30, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sunday, November 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 2, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, January 13, 2026ASSIGNED TO EXAMINER
Friday, January 16, 2026NON-FINAL ACTION WRITTEN
Saturday, January 17, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Related Keywords

medicine better towards genfit diseases pharmaceutical gastroenterological inflammatory immune cancer disorders metabolic gastrointestinal preparations